Published in Proc (Bayl Univ Med Cent) on April 01, 2004
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 11.06
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA (2003) 10.55
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Sudden cardiac death. Circulation (1998) 9.41
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Sudden cardiac death in the United States, 1989 to 1998. Circulation (2001) 7.92
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med (2000) 6.27
A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med (2004) 5.76
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol (1994) 5.02
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56
Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation (2000) 4.32
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation (1996) 4.01
Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation (1998) 3.68
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA (1996) 3.54
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol (2003) 3.38
Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation (2002) 3.32
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation (2002) 2.97
Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation (2001) 2.85
Mechanisms and models in heart failure: A combinatorial approach. Circulation (1999) 2.60
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol (2002) 2.50
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet (2002) 2.49
Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation (2002) 2.46
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation (2002) 2.43
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation (1997) 2.26
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11
Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J (2002) 2.07
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation (2001) 2.05
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation (2003) 1.99
Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol (2003) 1.97
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation (2002) 1.93
Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation (2002) 1.89
Physical activity and coronary heart disease risk in men: does the duration of exercise episodes predict risk? Circulation (2000) 1.82
The natural history of borderline isolated systolic hypertension. N Engl J Med (1993) 1.82
Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol (1998) 1.75
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (2003) 1.71
Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension (2000) 1.70
Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol (2003) 1.68
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet (2002) 1.68
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol (1997) 1.68
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol (1995) 1.55
Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation (1997) 1.55
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol (2001) 1.46
Obesity is an environmental issue. Atherosclerosis (1999) 1.44
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation (1999) 1.34
Demographics and cardiology, 1950-2050. J Am Coll Cardiol (2000) 1.30
Sudden death prevention in patients with advanced ventricular dysfunction. Circulation (1993) 1.23
Coronary bypass surgery for chronic angina--1981. A perspective. Circulation (1982) 1.23
Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation (2003) 1.18
Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol (1998) 1.15
Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol (1997) 1.11
Medical advances in the treatment of congestive heart failure. Circulation (1993) 1.10
Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol (2000) 1.10
Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. J Am Coll Cardiol (2003) 1.02
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study). Am Heart J (2002) 1.00
Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol (2002) 0.99
Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol (2001) 0.98
Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation (2002) 0.98
Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome. Circulation (2003) 0.95
Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol (1998) 0.93
Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol (1998) 0.92
Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation (1997) 0.82
The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol (1995) 0.80
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol (2009) 2.91
The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol (2009) 2.20
Thrombotic occlusion of the aortic ostia of saphenous venous grafts early after coronary artery bypass grafting by using the Symmetry aortic connector system. J Thorac Cardiovasc Surg (2002) 2.04
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA (2009) 1.75
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis (2011) 1.70
AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol (2008) 1.54
The editor's roundtable: psoriasis, inflammation, and coronary artery disease. Am J Cardiol (2008) 1.45
Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med (2003) 1.43
The editor's roundtable: atherosclerosis regression. Am J Cardiol (2008) 1.42
The editor's roundtable: JUPITER follow-up. Am J Cardiol (2011) 1.39
Diagnosis of congenital unicuspid aortic valve by 64-slice cardiac computed tomography. Proc (Bayl Univ Med Cent) (2008) 1.38
The editor's roundtable: pathophysiology and management of hyponatremia and the role of vasopressin antagonists. Am J Cardiol (2011) 1.38
Preoperative exclusion of significant coronary artery disease by 64-slice CT coronary angiography in a patient with a left atrial myxoma. Proc (Bayl Univ Med Cent) (2006) 1.34
Mitral "annular" calcium forming a complete circle "O" causing mitral stenosis in association with a stenotic congenitally bicuspid aortic valve and severe coronary artery disease. Am J Geriatr Cardiol (2006) 0.96
Isolated ventricular septal defect caused by nonpenetrating trauma to the chest. Proc (Bayl Univ Med Cent) (2002) 0.85
AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. Am J Cardiol (2010) 0.82
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol (2007) 0.82
Syndrome of protein C deficiency and anterior wall acute myocardial infarction at a young age from a single coronary occlusion with otherwise normal coronary arteries. Am J Cardiol (2003) 0.81
The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk. Am J Cardiol (2005) 0.81
The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular risk. Am J Cardiol (2008) 0.81
Isolated atrial amyloidosis and the importance of molecular classification. Proc (Bayl Univ Med Cent) (2013) 0.80
The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure. Am J Cardiol (2010) 0.80
Community violence exposure and post-traumatic stress reactions among Gambian youth: the moderating role of positive school climate. Soc Psychiatry Psychiatr Epidemiol (2009) 0.80
Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol (2002) 0.80
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2006) 0.80
The Editor's Roundtable: cardiac valve surgery. Am J Cardiol (2007) 0.79
The editor's roundtable: the JUPITER trial--initial results and clinical implications. Am J Cardiol (2009) 0.79
The editor's roundtable: contrast-induced nephropathy. Am J Cardiol (2007) 0.79
A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78
The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol (2008) 0.78
The editor's roundtable: Hypertension in African Americans and other non-Caucasian ethnic groups. Am J Cardiol (2010) 0.78
AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol (2010) 0.78
The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Am J Cardiol (2008) 0.78
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2009) 0.77
The Editor's roundtable: diabetes mellitus and coronary heart disease. Am J Cardiol (2006) 0.77
The editor's roundtable: Acute decompensated heart failure. Am J Cardiol (2007) 0.77
The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. Am J Cardiol (2012) 0.76
The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk. Am J Cardiol (2008) 0.76
The editor's roundtable: high-density lipoprotein cholesterol. Am J Cardiol (2007) 0.76
The editor's roundtable: medical management of atrial fibrillation. Am J Cardiol (2012) 0.76
Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Am J Cardiol (2010) 0.76
The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol (2008) 0.76
Cardiovascular care for women: the 10-Q Report and beyond. Am J Cardiol (2013) 0.75
The editor's roundtable: sudden cardiac death in athletes. Am J Cardiol (2007) 0.75
Dyspnea with hemoglobin SC disease. Proc (Bayl Univ Med Cent) (2002) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2003) 0.75
Joseph Allen Kuhn, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2008) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2010) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2007) 0.75
Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2013) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2003) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2009) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2012) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2012) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2010) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2011) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2009) 0.75
Acute myocardial infarction at 25 years of age. Proc (Bayl Univ Med Cent) (2004) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2007) 0.75
Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2005) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2010) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2011) 0.75
Massive bloody pericardial effusion as an initial manifestation of chronic kidney disease. Proc (Bayl Univ Med Cent) (2013) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2010) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2009) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2011) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2007) 0.75
Not congenital atresia of the aortic isthmus, but acquired complete occlusion in congenital aortic coarctation. Catheter Cardiovasc Interv (2002) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2008) 0.75
Severe late (16 years) dysfunction of a bioprosthesis in the mitral valve position without dysfunction of a bioprosthesis in the aortic valve position. Proc (Bayl Univ Med Cent) (2004) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2012) 0.75
Congenitally bicuspid aortic valve in brothers: coarctation of the aorta with a normally functioning aortic valve in one and no coarctation but severe aortic stenosis in the other. Proc (Bayl Univ Med Cent) (2013) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2008) 0.75
David Wesley Barnett, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2007) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2012) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2008) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2011) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2002) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2006) 0.75
Angina pectoris, dyspnea, fatigue, and edema after a non-ST-segment-elevation myocardial infarct. Proc (Bayl Univ Med Cent) (2006) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2007) 0.75
The myth of the Bernheim syndrome. Proc (Bayl Univ Med Cent) (2013) 0.75
43.3-year durability of a Smeloff-Cutter ball-caged mitral valve. Ann Thorac Surg (2011) 0.75
A 105-year-old heart. Am J Geriatr Cardiol (2007) 0.75
Thoralf Mauritz Sundt III, MD: A Conversation With the Editor. Am J Cardiol (2016) 0.75
Irving David Prengler, MD, MBA: a conversation with the editor. Proc (Bayl Univ Med Cent) (2006) 0.75
The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation. Am J Cardiol (2011) 0.75
The editor's roundtable: anemia and cardiovascular disease. Am J Cardiol (2011) 0.75
PAUL A. GRAYBURN, MD, on percutaneous mitral repair with the MitraClip™ device: a conversation with the editor. Am J Cardiol (2011) 0.75
The editor's roundtable: concurrent hypertension and dyslipidemia. Am J Cardiol (2006) 0.75
Zaven Hagop Chakmakjian, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2007) 0.75
The Personal Professor: continuing medical education meets the new media. Am J Cardiol (2002) 0.75
William Watts Parmley, MD: a conversation with the editor. Am J Cardiol (2002) 0.75
The heaviest known operatively-excised aortic valve. Am J Cardiol (2006) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2005) 0.75
Statin therapy in acute coronary syndrome. Am J Cardiol (2006) 0.75
Robert Gary Mennel, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2006) 0.75
The editor's roundtable: contrast agents and risk for contrast-induced nephropathy. Am J Cardiol (2011) 0.75
Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2013) 0.75
Lynne Anne Marcum Kirk, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2007) 0.75